Literature DB >> 15780728

A strong CD8+ T cell response is elicited using the synthetic polypeptide from the C-terminus of the circumsporozoite protein of Plasmodium berghei together with the adjuvant QS-21: quantitative and phenotypic comparison with the vaccine model of irradiated sporozoites.

Valentin Meraldi1, Jackeline F Romero, Charlotte Kensil, Giampietro Corradin.   

Abstract

Stable protective immunity can be achieved against malaria by the injection of radiation-attenuated sporozoites (gamma-spz) and is mediated by IFN-gamma producing CD8+ T cells targeting the pre-erythrocytic stages. An efficient malaria vaccine should mimic this immunity. We compared the immune response specific for the circumsporozoite protein (CSP) of Plasmodium berghei (P. berghei), an important target of this protective response, elicited in mice immunized with the long synthetic polypeptide (LSP) PbCS 242-310, representing the C-terminus of the CSP of P. berghei, with the adjuvant QS-21 or injected with gamma-spz. The ex vivo evaluation of the CD8+ T cell response by IFN-gamma ELISPOT assay revealed that the injection of LSP with QS-21 induced, compared to gamma-spz, a similar frequency of peptide-specific lymphocytes in the spleen but a eight-fold increase in the draining lymph-nodes. A very high frequency of CD8+ T cells, specific for the sequence PbCS 245-253, a H-2Kd-restricted CTL epitope, was obtained in the liver and spleen of mice immunized with the two regimens. Even though the frequency of H-2Kd PbCS 245-253 multimer+, CD8+ T cells was higher in gamma-spz immunized mice, the frequency of IFN-gamma producing CD8+ T cells was comparable. The phenotype of the CD8+ T cell responses was characterized with the help H-2Kd PbCS 245-253 multimer and most of the CSP-specific CD8+ T cells represented an intermediate subset between effector and central memory with CD44(high), CD45RB(high), CD62L(low) and CD122(high). The number of memory CD8+ T cells decreased after the last LSP immunization but could be boosted to higher level with live spz. The unique combination of LSP PbCS 242-310 and the adjuvant QS-21 induced an immune response that was comparable in terms of quality to the one generated with gamma-spz. This confirmed the potential of LSP as malaria vaccine candidates as well as for the study of the repertoire of targets of protective immunity in the gamma-spz vaccine model.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15780728     DOI: 10.1016/j.vaccine.2004.10.044

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  10 in total

1.  Antigen-specific CD8+ T cells and the development of central memory during Mycobacterium tuberculosis infection.

Authors:  Arati Kamath; Joshua S M Woodworth; Samuel M Behar
Journal:  J Immunol       Date:  2006-11-01       Impact factor: 5.422

Review 2.  Carbohydrate-based immune adjuvants.

Authors:  Nikolai Petrovsky; Peter D Cooper
Journal:  Expert Rev Vaccines       Date:  2011-04       Impact factor: 5.217

3.  A novel chimeric Plasmodium vivax circumsporozoite protein induces biologically functional antibodies that recognize both VK210 and VK247 sporozoites.

Authors:  Anjali Yadava; Jetsumon Sattabongkot; Michael A Washington; Lisa A Ware; Victoria Majam; Hong Zheng; Sanjai Kumar; Christian F Ockenhouse
Journal:  Infect Immun       Date:  2006-12-11       Impact factor: 3.441

4.  Polymeric linear Peptide chimeric vaccine-induced antimalaria immunity is associated with enhanced in vitro antigen loading.

Authors:  Luciana M Silva-Flannery; Monica Cabrera-Mora; Megan Dickherber; Alberto Moreno
Journal:  Infect Immun       Date:  2009-02-23       Impact factor: 3.441

5.  A randomized pilot trial testing the safety and immunologic effects of a MAGE-A3 protein plus AS15 immunostimulant administered into muscle or into dermal/subcutaneous sites.

Authors:  Craig L Slingluff; Gina R Petroni; Walter C Olson; Mark E Smolkin; Kimberly A Chianese-Bullock; Ileana S Mauldin; Kelly T Smith; Donna H Deacon; Nikole E Varhegyi; Sean B Donnelly; Caroline M Reed; Kristy Scott; Nadejda V Galeassi; William W Grosh
Journal:  Cancer Immunol Immunother       Date:  2015-11-18       Impact factor: 6.968

6.  Bacterium-like particles as multi-epitope delivery platform for Plasmodium berghei circumsporozoite protein induce complete protection against malaria in mice.

Authors:  Krystelle Nganou-Makamdop; Maarten L van Roosmalen; Sandrine A L Audouy; Geert-Jan van Gemert; Kees Leenhouts; Cornelus C Hermsen; Robert W Sauerwein
Journal:  Malar J       Date:  2012-02-20       Impact factor: 2.979

7.  Plasmodium berghei circumsporozoite protein encapsulated in oligomannose-coated liposomes confers protection against sporozoite infection in mice.

Authors:  Mohamad Alaa Terkawi; Yasuhiro Kuroda; Shinya Fukumoto; Sachi Tanaka; Naoya Kojima; Yoshifumi Nishikawa
Journal:  Malar J       Date:  2014-11-05       Impact factor: 2.979

8.  CD8+ T cell response in HLA-A*0201 transgenic mice is elicited by epitopes from SARS-CoV S protein.

Authors:  Kai Zhao; Binyan Yang; Yanquan Xu; Changyou Wu
Journal:  Vaccine       Date:  2010-08-13       Impact factor: 3.641

Review 9.  Malaria vaccine adjuvants: latest update and challenges in preclinical and clinical research.

Authors:  Elena Mata; Aiala Salvador; Manoli Igartua; Rosa María Hernández; José Luis Pedraz
Journal:  Biomed Res Int       Date:  2013-04-23       Impact factor: 3.411

10.  Suppression of established hepatocarcinoma in adjuvant only immunotherapy: alum triggers anti-tumor CD8+ T cell response.

Authors:  Bo Wang; Xuanyi Wang; Yumei Wen; Jing Fu; Hongyang Wang; Zhangmei Ma; Yan Shi; Bin Wang
Journal:  Sci Rep       Date:  2015-12-09       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.